ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AQNB - US0158578080
25.56 USD
-0.04 (-0.14%)
We assign a fundamental rating of 3 out of 10 to AQNB. AQNB was compared to 26 industry peers in the Multi-Utilities industry. AQNB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AQNB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year AQNB was profitable.
- AQNB had a positive operating cash flow in the past year.
- In multiple years AQNB reported negative net income over the last 5 years.
- In the past 5 years AQNB always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of -0.27%, AQNB is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
- AQNB has a worse Return On Equity (-0.80%) than 96.15% of its industry peers.
- AQNB's Return On Invested Capital of 3.16% is on the low side compared to the rest of the industry. AQNB is outperformed by 88.46% of its industry peers.
- AQNB had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.94%.
- The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.27% | ||
| ROE | -0.8% | ||
| ROIC | 3.16% |
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
1.3 Margins
- With a Operating Margin value of 21.55%, AQNB perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
- In the last couple of years the Operating Margin of AQNB has declined.
- With a decent Gross Margin value of 73.94%, AQNB is doing good in the industry, outperforming 73.08% of the companies in the same industry.
- In the last couple of years the Gross Margin of AQNB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.55% | ||
| PM (TTM) | N/A | ||
| GM | 73.94% |
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
- Compared to 1 year ago, AQNB has more shares outstanding
- Compared to 5 years ago, AQNB has more shares outstanding
- Compared to 1 year ago, AQNB has an improved debt to assets ratio.
2.2 Solvency
- AQNB has an Altman-Z score of 1.31. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
- AQNB's Altman-Z score of 1.31 is amongst the best of the industry. AQNB outperforms 96.15% of its industry peers.
- AQNB has a Debt/Equity ratio of 1.33. This is a high value indicating a heavy dependency on external financing.
- AQNB has a better Debt to Equity ratio (1.33) than 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.33 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.31 |
ROIC/WACC0.45
WACC7.04%
2.3 Liquidity
- A Current Ratio of 1.23 indicates that AQNB should not have too much problems paying its short term obligations.
- AQNB has a Current ratio of 1.23. This is amongst the best in the industry. AQNB outperforms 88.46% of its industry peers.
- AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
- AQNB's Quick ratio of 1.03 is amongst the best of the industry. AQNB outperforms 88.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
- AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.79%.
- Measured over the past years, AQNB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.38% on average per year.
- The Revenue for AQNB has decreased by -23.92% in the past year. This is quite bad
- The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
3.2 Future
- Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 4.09% on average per year.
- Based on estimates for the next years, AQNB will show a small growth in Revenue. The Revenue will grow by 2.30% on average per year.
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- AQNB is valuated quite expensively with a Price/Earnings ratio of 77.45.
- Based on the Price/Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
- AQNB is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 69.74, AQNB can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. AQNB is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 77.45 | ||
| Fwd PE | 69.74 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.54 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
5. Dividend
5.1 Amount
- AQNB has a Yearly Dividend Yield of 6.52%, which is a nice return.
- AQNB's Dividend Yield is rather good when compared to the industry average which is at 4.14. AQNB pays more dividend than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, AQNB pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.52% |
5.2 History
- The dividend of AQNB has a limited annual growth rate of 0.06%.
- AQNB has been paying a dividend for over 5 years, so it has already some track record.
- AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
- The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-569.86%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079
NYSE:AQNB (1/16/2026, 8:04:00 PM)
25.56
-0.04 (-0.14%)
Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners74.14%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.64B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts68.33
Price Target20.21 (-20.93%)
Short Float %0%
Short Ratio2.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.52% |
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date03-13 2026-03-13 (0.49)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)-8.36%
PT rev (3m)-10.33%
EPS NQ rev (1m)-9.38%
EPS NQ rev (3m)-24.82%
EPS NY rev (1m)0%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 77.45 | ||
| Fwd PE | 69.74 | ||
| P/S | 8.22 | ||
| P/FCF | N/A | ||
| P/OCF | 42.16 | ||
| P/B | 4.23 | ||
| P/tB | 6.02 | ||
| EV/EBITDA | 28.54 |
EPS(TTM)0.33
EY1.29%
EPS(NY)0.37
Fwd EY1.43%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.37%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.27% | ||
| ROE | -0.8% | ||
| ROCE | 4% | ||
| ROIC | 3.16% | ||
| ROICexc | 3.18% | ||
| ROICexgc | 3.56% | ||
| OM | 21.55% | ||
| PM (TTM) | N/A | ||
| GM | 73.94% | ||
| FCFM | N/A |
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.33 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.76 | ||
| Cap/Depr | 208.02% | ||
| Cap/Sales | 34.55% | ||
| Interest Coverage | 1.49 | ||
| Cash Conversion | 51.11% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 1.31 |
F-Score4
WACC7.04%
ROIC/WACC0.45
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year48.7%
EBIT Next 3Y21.37%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%
ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 / AQNB FAQ
Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?
ChartMill assigns a fundamental rating of 3 / 10 to AQNB.
What is the valuation status of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?
ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB). This can be considered as Overvalued.
How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?
ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) has a profitability rating of 3 / 10.
How financially healthy is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?
The financial health rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 4 / 10.
Can you provide the dividend sustainability for AQNB stock?
The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.